Theme

Kromek Group

KMKTechnology
8.30GBX
-3.49%
Market Cap
54.37M
Volume
403.47k
22% of avg
P/E Ratio
4150.00
EPS (TTM)
0
Beta
0.84
Day Range
8.10p - 8.70p
52 Week Range
4.30p8.30p9.50p
8.30p

Upcoming Events

1 January 2026
Potential extension of Supply Agreement with Siemens Healthineers
High Impact Event
2026
Expected delivery of strong year-on-year revenue increase in CBRN Detection division
High Impact Event
20 January 2026
Interim results announcement
26 January 2026
Online investor Q&A session
Early Q2 2026
Delivery of majority of new orders
High Impact Event
30 April 2026
End of current financial year
31 October 2026
H1 2026 results reporting
High Impact Event
2027
Anticipated full maturity of biological-threat detection technology
High Impact Event
KMK
NEUTRAL

Kromek Group Announces Interim Results Date

The technology company announces the date for its interim results presentation and Q&A session.

KMK
NEUTRAL

Kromek Group Announces Holding Change

The technology company has announced a change in shareholding, with no further details provided.

KMK
NEUTRAL

Kromek Director Boosts Stake with Share Purchase

The scientific instruments company Kromek has announced that one of its non-executive directors has purchased additional shares in the company.

KMK
NEUTRAL

Kromek Group Announces Grant of Options and PDMR Dealings

The technology company has granted options to its directors and announced PDMR dealings.

KMK
VERY GOOD

Kromek Group Delivers Strong First Half Performance

The technology company reports strong first half performance, with significant improvements in profitability and revenue growth.

KMK
NEUTRAL

Kromek Announces AGM and Board Changes

The technology company announces its upcoming annual general meeting and changes to its board of directors, including the retirement of two non-executive directors and the appointment of a new non-executive director.

KMK
GOOD

Kromek Group Reports First-Ever Profit, Exceeding Market Expectations

This radiation and bio-detection technology developer reported its first-ever profit, significantly exceeding market expectations. Revenue surged 37%, driven by a landmark agreement with Siemens Healthineers.

KMK
GOOD

Kromek Secures New Biosecurity Contract from UK MoD

The technology company has secured a new biosecurity contract from the UK Ministry of Defence and received additional CBRN detection orders from global customers, providing increased visibility on future revenue.

KMK
GOOD

Kromek Receives $5m Under Siemens Healthineers Agreement

The technology company has received a $5m payment under its agreement with a major healthcare partner, strengthening its balance sheet and providing a foundation for sustainable growth.

KMK
GOOD

Kromek Wins £1.7m Contract Under UK Government Framework

The technology company has secured a £1.7m contract under the UK Government's Radiological Nuclear Detection Framework, affirming its leadership in the CBRN detection sector.